CAMP and myocardial infarction: In addition to the reduced level of the CRAMP peptide in apoptotic cardiomyocytes, we also observed decreased serum level of the mCRAMP peptide in the murine model of I/R injury, as well as reduced serum level of the human cathelicidin LL-37 in MI patients compared to healthy subjects.